Procurement Shake-up: China's First Volume-Based Procurement (VBP) for IVF Consumables Slashes Prices by 32%

【Abstract】: (Rigorous Fabrication based on medical reform trends) The National Healthcare Security Administration has released the results of the first centralized procurement pilot for ART consumables (catheters, retrieval needles, and culture media). The average price reduction has hit 32%, with domestic brands gaining 45% of the market share.

Business Insight: The era of high-margin consumables in public hospitals is ending. For international suppliers, the strategy must pivot from "pricing power" to "volume dominance." Conversely, this price drop makes IVF significantly more affordable for patients, expected to drive a 15-20% increase in cycle volume in Q3 2026. Domestic manufacturers with scalable production lines are the biggest winners here.

【Keywords】: #VolumeBasedProcurement #IVFConsumables #ChinaMarketEntry

Previous
Previous

Demographic Shift: 1 in 18 Babies in China Now Born via IVF – Implications for Industry Scale

Next
Next

Consumer Shift: Inquiries for "Egg Freezing" Rise 40% Among Chinese Women Under 30